Why Monopar Therapeutics (MNPR) is a Smart Choice for Trend Investing

Investing based on trends can be highly profitable, as the saying goes, "the trend is your friend." However, determining whether a trend will continue or reverse can be quite difficult.

A trend may change direction suddenly, which can result in losses for short-term traders. To successfully invest in trending stocks, it is essential to confirm that the trend is backed by solid fundamentals and favorable earnings estimates, which can help sustain the stock's momentum.

One effective method to identify potential winners is through the "Recent Price Strength" screening process. This screening helps investors find stocks with strong fundamentals that are experiencing upward price movement. It focuses on stocks that are trading near the upper end of their 52-week high and low range, a clear indicator of market optimism.

Monopar Therapeutics Inc.

Among the many stocks that passed this screening is Monopar Therapeutics (MNPR). Here are some compelling reasons why MNPR stands out for trend investing.

Firstly, the stock has demonstrated an incredible price increase of 842.7% over the past 12 weeks, indicating that investors are willing to pay more for its potential.

However, evaluating just the longer-term price performance is not enough; it's crucial to observe if this trend is maintained in the short term as well. MNPR has additionally risen by 54% over the last four weeks, confirming that its upward trend is intact.

Furthermore, MNPR is trading at 83% of its 52-week High-Low Range, suggesting it may be nearing a breakout.

From a fundamental perspective, MNPR has a Zacks Rank of #2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and earnings surprises—key factors that influence stock prices in the near term.

The Zacks Rank system employs four earnings estimate factors to categorize stocks from #1 (Strong Buy) to #5 (Strong Sell). Notably, stocks ranked #1 have historically delivered an average annual return of +25% since 1988, highlighting the effectiveness of this ranking methodology.

Adding to MNPR's appeal, it holds an Average Broker Recommendation of #1 (Strong Buy). This signals that analysts are optimistic about the stock's near-term price trajectory.

Considering all these factors, it seems likely that MNPR's price trend will remain on an upward path for the foreseeable future.

In addition to MNPR, investors can find several other stocks that meet the criteria of the "Recent Price Strength" screen. Taking these into consideration can further enhance your investment portfolio.

It's worthwhile to note that this screening tool is just one method to identify potential winning stocks. Depending on your investment strategy, you can explore over 45 distinct Zacks Premium Screens that are designed to outperform the market.

Ultimately, the cornerstone of a successful stock-picking strategy is its historical performance. Tools like the Zacks Research Wizard can help you backtest different strategies, providing valuable insights into past effectiveness.

Consider taking advantage of a free trial of the Research Wizard today to refine your investment approach.

Monopar, Investing, Stocks